Elevated urinary levels of 8-oxo-2′-deoxyguanosine, (5′R)- and (5′S)-8,5′-cyclo-2′-deoxyadenosines, and 8-iso-prostaglandin F2α as potential biomarkers of oxidative stress in patients with prediabetes

DNA Repair

Volumn 48, Issue , 2016, Pages 1-7

  Kant, Melis ^a   Akış, Merve ^a   Çalan, Mehmet ^b   Arkan, Tuğba ^c   Bayraktar, Fırat ^a   Dizdaroglu, Miral ^d   İşlekel, Hüray ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Izmir SSK Educ and Res Hospital   (Turkey)

^c Derince Education and Research Hospital   (Turkey)

^d NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

8,5 cyclo 2 Deoxyadenosines; 8 iso Prostaglandin F2 ; 8 Oxo 2 deoxyguanosine; Lipid peroxidation; Oxidatively induced DNA damage; Prediabetes

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; 8,5 CYCLO 2' DEOXYADENOSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; DEOXYADENOSINE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITROGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; 8,5'-CYCLO-2'-DEOXYADENOSINE; 8-EPI-PROSTAGLANDIN F2ALPHA; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; DNA DAMAGE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE SAMPLING; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; PROCEDURES; URINE;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, LIQUID; DEOXYADENOSINES; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DINOPROST; DNA DAMAGE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDIABETIC STATE; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES;

EID: 84995752401     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2016.09.004     Document Type: Article

References (46)

1. [1] Song, F., Jia, W., Yao, Y., Hu, Y., Lei, L., Lin, J., Sun, X., Liu, L., Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin. Sci. 112 (2007), 599–606.
2. [2] Tabák, A.G., Herder, C., Rathmann, W., Brunner, E.J., Kivimäki, M., Prediabetes A high-risk state for diabetes development. Lancet 379 (2012), 2279–2290.
3. [3] Hopps, E., Noto, D., Caimi, G., Averna, M.R., A novel component of the metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovasc. Dis. 20 (2010), 72–77.
4. [4] Maritim, A.C., Sanders, R.A., Watkins, J.B., Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17 (2003), 24–38.
5. [5] Pereira, C.S., Molz, P., Palazzo, R.P., de Freitas, T.A.B., Maluf, S.W., Horta, J.A., Prá, D., Franke, S.I.R., DNA damage and cytotoxicity in adult subjects with prediabetes. Mutat. Res.—Genet. Toxicol. Environ. Mutagen. 48 (2013), 581–585.
6. [6] Tabak, O., Gelisgen, R., Erman, H., Erdenen, F., Muderrisoglu, C., Aral, H., Uzun, H., Oxidative lipid protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin. Invest. Med. 34 (2011), E163–171.
7. [7] Friedberg, E., DNA damage and repair. Nature 421 (2003), 436–440.
8. [8] Kasai, H., Hayami, H., Yamaizumi, Z., Saitô, H., Nishimura, S., Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. Nucleic Acids Res. 12 (1984), 2127–2136.
9. [9] Valavanidis, A., Vlachogianni, T., Fiotakis, C., 8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health. C: Environ. Carcinog. Ecotoxicol. Rev. 27 (2009), 120–139.
10. [10] Kaneko, T., Tahara, S., Matsuo, M., Non-linear accumulation of 8-hydroxy-2′-deoxyguanosine a marker of oxidized DNA damage, during aging. Mutat. Res.—DNAging Genet. Instab. Aging 316 (1996), 277–285.
11. [11] Cooke, M.S., Evans, M.D., Dizdaroglu, M., Lunec, J., Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17 (2003), 1195–1214.
12. [12] Evans, M.D., Olinski, R., Loft, S., Cooke, M.S., Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J. 24 (2010), 1249–1260.
13. [13] Dizdaroglu, M., Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett. 327 (2012), 26–47.
14. [14] Jaruga, P., Dizdaroglu, M., 8,5′-Cyclopurine-2′-deoxynucleosides in DNA: mechanisms of formation measurement, repair and biological effects. DNA Repair (Amst.) 7 (2008), 1413–1425.
15. [15] Dizdaroglu, M., Oxidatively induced DNA damage and its repair in cancer. Mutat. Res. Rev. Mutat. Res. 763 (2015), 212–245.
16. [16] Jaruga, P., Dizdaroglu, M., Identification and quantification of (5′R)- and (5′S)-8,5′-cyclo-2′-deoxyadenosines in human urine as putative biomarkers of oxidatively induced damage to DNA. Biochem. Biophys. Res. Commun. 397 (2010), 48–52.
17. [17] Dizdaroglu, M., Jaruga, P., Rodriguez, H., Measurement of 8-hydroxy-2′-deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res., 29, 2001, E12.
18. [18] Jaruga, P., Rozalski, R., Jawien, A., Migdalski, A., Olinski, R., Dizdaroglu, M., DNA damage products (5′R)- and (5′S)-8,5′-cyclo-2′-deoxyadenosines as potential biomarkers in human urine for atherosclerosis. Biochemistry 51 (2012), 1822–1824.
19. [19] Milne, G.L., Dai, Q., Roberts, L.J., The isoprostanes-25 years later. Biochim. Biophys. Acta 1851 (2015), 433–445.
20. [20] Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F., Roberts, L.J., A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 9383–9387.
21. [21] Teng, Y.-H., Wang, C.-W., Liao, Y.-T., Yang, M.-W., Liu, T.-Y., Quantification of urinary 8-iso-prostaglandin F(2 alpha) using liquid chromatography-tandem mass spectrometry during cardiac valve surgery. J. Clin. Lab. Anal. 24 (2010), 237–245.
22. 4 poisoning?. Free Radic. Biol. Med. 38 (2005), 698–710.
23. [23] Roberts, L.J., Morrow, J.D., The generation and actions of isoprostanes. Biochim. Biophys. Acta—Lipids Lipid Metab. 1345 (1997), 121–135.
24. [24] Roberts, L.J., Morrow, J.D., Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 2 (2000), 505–513.
25. [25] Al-Aubaidy, H.A., Jelinek, H.F., 8-oxo-2′-deoxyguanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 15 (2010), 155–160.
26. [26] American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34:Suppl. 1 (2011), S62–S69.
27. [27] Portero McLellan, K.C., Wyne, K., Villagomez, E.T., Hsueh, W.A., Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther. Clin. Risk Manage. 10 (2014), 173–188.
28. [28] Tabak, O., Gelisgen, R., Erman, H., Erdenen, F., Muderrisoglu, C., Aral, H., Uzun, H., Oxidative lipid protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin. Invest. Med. 34 (2011), E163–E171.
29. [29] Zengi, A., Ercan, G., Caglayan, O., Tamsel, S., Karadeniz, M., Simsir, I., Harman, E., Kahraman, C., Orman, M., Cetinkalp, S., Ozgen, G., Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 119 (2011), 467–471.
30. [30] Zheng, F., Lu, W., Jia, C., Li, H., Wang, Z., Jia, W., Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine 37 (2010), 201–208.
31. [31] Broedbaek, K., Siersma, V., Henriksen, T., Weimann, A., Petersen, M., Andersen, J.T., Jimenez-Solem, E., Stovgaard, E.S., Hansen, L.J., Henriksen, J.E., Bonnema, S.J., de, N., Olivarius, F., Poulsen, H.E., De Fine Olivarius, N., Poulsen, H.E., Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care 34 (2011), 2594–2596.
32. [32] Chang, C.-M., Hsieh, C.-J., Huang, J.-C., Huang, I.-C., Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 49 (2012), 171–177.
33. [33] Al-Aubaidy, H.A., Jelinek, H.F., Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur. J. Endocrinol. 164 (2011), 899–904.
34. [34] Siegelaar, S.E., Barwari, T., Kulik, W., Hoekstra, J.B., DeVries, H.J., No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J. Diabetes Sci. Technol. 5 (2011), 86–92.
35. [35] Dzięgielewska-Gęsiak, S., et al. Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics. Oxid. Med. 2014 (2014), 111–118.
36. [36] Maschirow, L., Khalaf, K., Al-Aubaidy, H.A., Jelinek, H.F., Inflammation coagulation, endothelial dysfunction and oxidative stress in prediabetes—biomarkers as a possible tool for early disease detection for rural screening. Clin. Biochem. 48 (2015), 581–585.
37. [37] Pereira, C.S., Molz, P., Palazzo, R.P., de Freitas, T.A.B., Maluf, S.W., Horta, J.A., Prá, D., Franke, S.I.R., DNA damage and cytotoxicity in adult subjects with prediabetes. Mutat. Res. 753 (2013), 76–81.
38. [38] Poulsen, H.E., Oxidative DNA modifications. Exp. Toxicol. Pathol. 57 (2005), 161–169.
39. [39] Evans, M.D., Olinski, R., Loft, S., Cooke, M.S., Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J. 24 (2010), 1249–1260.
40. [40] Gackowski, D., Rozalski, R., Roszkowski, K., Jawien, A., Foksiński, M., Olinski, R., 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet. Free Radic. Res. 35 (2001), 825–832.
41. [41] Rozalski, R., Siomek, A., Gackowski, D., Foksinski, M., Gran, C., Klungland, A., Olinski, R., Substantial decrease of urinary 8-oxo-7,8-dihydroguanine, a product of the base excision repair pathway, in DNA glycosylase defective mice. Int. J. Biochem. Cell Biol. 37 (2005), 1331–1336.
42. [42] Cooke, M.S., Olinski, R., Loft, S., Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol. Biomarkers Prev. 17 (2008), 3–14.
43. [43] Cooke, M.S., Henderson, P.T., Evans, M.D., Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine. J. Clin. Biochem. Nutr. 45 (2009), 255–270.
44. [44] Brooks, P.J., Wise, D.S., Berry, D.A., Kosmoski, J.V., Smerdon, M.J., Somers, R.L., Mackie, H., Spoonde, A.Y., Ackerman, E.J., Coleman, K., Tarone, R.E., Robbins, J.H., The oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 275 (2000), 22355–22362.
45. [45] Kuraoka, I., Bender, C., Romieu, A., Cadet, J., Wood, R.D., Lindahl, T., Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 3832–3837.
46. [46] Montuschi, P., Barnes, P.J., Roberts, L.J., Isoprostanes: markers and mediators of oxidative stress. FASEB J. 18 (2004), 1791–1800.